Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Completed · Phase 2

Conditions studied: Pancreatic Cancer

In brief

RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. PURPOSE: This phase II trial is studying how well paclitaxel works in treating patients with unresectable locally advanced or metastatic pancreatic cancer.

Key facts

Study ID

NCT00111904

Run by

Theradex

People needed

43

Starts

2005-05-01

Last updated by the study team

2011-12-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Florida Cancer Specialists - Bonita Springs — Bonita Springs, Florida, United States
• Midwest Cancer Research Group, Incorporated — Skokie, Illinois, United States
• Louisiana Oncology Associates - Lafayette — Lafayette, Louisiana, United States
• St. Vincent's Comprehensive Cancer Center - Manhattan — New York, New York, United States
• Southwest Regional Cancer Center - Central — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.